Delirium and stereotypy from anticholinergic antiparkinson drugs.
1. This report describes two cases of psychotic syndrome from benztropine (Cogentin), which was used to treat haloperidol-induced extrapyramidal side effects. The patients' symptomatology meets DSM III criteria for delirium. Both patients displayed repetitive motor automatisms (stereotypy). 2. Symptomatology appeared one-to-two days after the start of benztropine 2 mg b.i.d. and subsided one-to-several days after benztropine was stopped. Treatment consisted of administration of sedative hypnotic drugs. 3. The literature on anticholinergic-induced psychotic syndromes is surveyed. Particular attention is drawn to the occurrence of stereotypy. 4. It is proposed, on the basis of a review of animal and clinical data, that stereotypies in delirious patients are related to muscarinic blockade in the central nervous system. This model is used to explain repetitive motor automatisms which are seen in Alzheimer's disease. 5. The paper concludes with brief guidelines for the management of anticholinergic delirium.
D000328:Adult; D000368:Aged; D001590:Benztropine / Q000009:adverse effects* / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced*; D003975:Diazepam / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D004984:Ethchlorvynol / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D010634:Phenobarbital / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D013239:Stereotyped Behavior / Q000187:drug effects*; D019966:Substance-Related Disorders / Q000188:drug therapy; D014326:Tropanes / Q000009:adverse effects*
D014326:Tropanes; D001590:Benztropine; D004984:Ethchlorvynol; D006220:Haloperidol; D007099:Imipramine; D003975:Diazepam; D010634:Phenobarbital